We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to Elevance Health (ELV) Q4 Earnings: Wall Street Forecasts for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Elevance Health (ELV - Free Report) will report quarterly earnings of $5.55 per share in its upcoming release, pointing to a year-over-year increase of 6.1%. It is anticipated that revenues will amount to $41.82 billion, exhibiting an increase of 5.4% compared to the year-ago quarter.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Given this perspective, it's time to examine the average forecasts of specific Elevance Health metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts' assessment points toward 'Revenue- Net investment income' reaching $465.65 million. The estimate indicates a year-over-year change of +24.8%.
Analysts forecast 'Revenue- Premiums' to reach $34.72 billion. The estimate indicates a change of +3.2% from the prior-year quarter.
Analysts predict that the 'Revenue- Service fees' will reach $1.95 billion. The estimate indicates a year-over-year change of +3.5%.
The combined assessment of analysts suggests that 'Revenue- Product revenue' will likely reach $5.20 billion. The estimate indicates a year-over-year change of +25.6%.
According to the collective judgment of analysts, 'Medical Membership - Medicaid' should come in at 10,816.22 thousand. The estimate is in contrast to the year-ago figure of 11,571 thousand.
The collective assessment of analysts points to an estimated 'Medical Membership - Employer Group Risk-Based' of 3,795.09 thousand. Compared to the present estimate, the company reported 3,988 thousand in the same quarter last year.
The consensus estimate for 'Medical Membership - Total Commercial Risk-Based' stands at 4,818.63 thousand. Compared to the present estimate, the company reported 4,777 thousand in the same quarter last year.
The average prediction of analysts places 'Medical Membership - Medicare - Medicare Supplement' at 930.38 thousand. Compared to the current estimate, the company reported 947 thousand in the same quarter of the previous year.
Analysts expect 'Medical Membership - Individual' to come in at 1,023.55 thousand. Compared to the current estimate, the company reported 789 thousand in the same quarter of the previous year.
It is projected by analysts that the 'Medical Membership - Total Commercial Fee-Based' will reach 27,003.35 thousand. Compared to the current estimate, the company reported 26,636 thousand in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Benefit Expense Ratio' should arrive at 89.6%. The estimate compares to the year-ago value of 89.4%.
The consensus among analysts is that 'Medical Membership - Medicare - Medicare Advantage' will reach 2,072.49 thousand. The estimate is in contrast to the year-ago figure of 1,977 thousand.
Elevance Health shares have witnessed a change of +1.1% in the past month, in contrast to the Zacks S&P 500 composite's +0.9% move. With a Zacks Rank #2 (Buy), ELV is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Countdown to Elevance Health (ELV) Q4 Earnings: Wall Street Forecasts for Key Metrics
Wall Street analysts forecast that Elevance Health (ELV - Free Report) will report quarterly earnings of $5.55 per share in its upcoming release, pointing to a year-over-year increase of 6.1%. It is anticipated that revenues will amount to $41.82 billion, exhibiting an increase of 5.4% compared to the year-ago quarter.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Given this perspective, it's time to examine the average forecasts of specific Elevance Health metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts' assessment points toward 'Revenue- Net investment income' reaching $465.65 million. The estimate indicates a year-over-year change of +24.8%.
Analysts forecast 'Revenue- Premiums' to reach $34.72 billion. The estimate indicates a change of +3.2% from the prior-year quarter.
Analysts predict that the 'Revenue- Service fees' will reach $1.95 billion. The estimate indicates a year-over-year change of +3.5%.
The combined assessment of analysts suggests that 'Revenue- Product revenue' will likely reach $5.20 billion. The estimate indicates a year-over-year change of +25.6%.
According to the collective judgment of analysts, 'Medical Membership - Medicaid' should come in at 10,816.22 thousand. The estimate is in contrast to the year-ago figure of 11,571 thousand.
The collective assessment of analysts points to an estimated 'Medical Membership - Employer Group Risk-Based' of 3,795.09 thousand. Compared to the present estimate, the company reported 3,988 thousand in the same quarter last year.
The consensus estimate for 'Medical Membership - Total Commercial Risk-Based' stands at 4,818.63 thousand. Compared to the present estimate, the company reported 4,777 thousand in the same quarter last year.
The average prediction of analysts places 'Medical Membership - Medicare - Medicare Supplement' at 930.38 thousand. Compared to the current estimate, the company reported 947 thousand in the same quarter of the previous year.
Analysts expect 'Medical Membership - Individual' to come in at 1,023.55 thousand. Compared to the current estimate, the company reported 789 thousand in the same quarter of the previous year.
It is projected by analysts that the 'Medical Membership - Total Commercial Fee-Based' will reach 27,003.35 thousand. Compared to the current estimate, the company reported 26,636 thousand in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Benefit Expense Ratio' should arrive at 89.6%. The estimate compares to the year-ago value of 89.4%.
The consensus among analysts is that 'Medical Membership - Medicare - Medicare Advantage' will reach 2,072.49 thousand. The estimate is in contrast to the year-ago figure of 1,977 thousand.
View all Key Company Metrics for Elevance Health here>>>
Elevance Health shares have witnessed a change of +1.1% in the past month, in contrast to the Zacks S&P 500 composite's +0.9% move. With a Zacks Rank #2 (Buy), ELV is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>